15th World ADC London will bring together over 1000 ADC enthusiasts to maximise the therapeutic index of antibody-drug conjugates (ADCs). This event, now in its 15th year, will focus on accelerating ADC development from concept to approved therapy. With 120+ world-class speakers from companies like Daiichi Sankyo, AstraZeneca, Pfizer, and Merck, the conference will cover R&D, clinical development, and manufacturing for ADCs.
Attendees will have access to networking opportunities, scientific sessions, and industry insights from leading experts. Whether you’re new to ADCs or an experienced researcher, this conference is essential for anyone in the ADC field.